Volltext verfügbar nach Anmeldung bzw. im Campus-Netz.
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
In: Molecular Cancer, Jg. 21 (2022-06-10), Heft 1
Online
academicJournal
Zugriff:
Titel: |
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
|
---|---|
Autor/in / Beteiligte Person: | Berlak, Mareike ; Tucker, Elizabeth ; Dorel, Mathurin ; Winkler, Annika ; McGearey, Aleixandria ; Rodriguez-Fos, Elias ; da Costa, Barbara Martins ; Barker, Karen ; Fyle, Elicia ; Calton, Elizabeth ; Eising, Selma ; Ober, Kim ; Hughes, Deborah ; Koutroumanidou, Eleni ; Carter, Paul ; Stankunaite, Reda ; Proszek, Paula ; Jain, Neha ; Rosswog, Carolina ; Dorado-Garcia, Heathcliff ; Molenaar, Jan Jasper ; Hubank, Mike ; Barone, Giuseppe ; Anderson, John ; Lang, Peter ; Deubzer, Hedwig Elisabeth ; Künkele, Annette ; Fischer, Matthias ; Eggert, Angelika ; Kloft, Charlotte ; Henssen, Anton George ; Boettcher, Michael ; Hertwig, Falk ; Blüthgen, Nils ; Chesler, Louis ; Schulte, Johannes Hubertus |
Link: | |
Zeitschrift: | Molecular Cancer, Jg. 21 (2022-06-10), Heft 1 |
Veröffentlichung: | 2022 |
Medientyp: | academicJournal |
ISSN: | 1476-4598 (print) |
DOI: | 10.1186/s12943-022-01583-z |
Sonstiges: |
|